In Vivo Evaluation of Indium-111–Labeled 800CW as a Necrosis-Avid Contrast Agent

PURPOSE: Current clinical measurements for tumor treatment efficiency rely often on changes in tumor volume measured as shrinkage by CT or MRI, which become apparent after multiple lines of treatment and pose a physical and psychological burden on the patient. Detection of therapy-induced cell death...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Imaging Biol
Autori principali: Stroet, Marcus C. M., de Blois, Erik, Stuurman, Debra C., de Ridder, Corrina M. A., Haeck, Joost, Seimbille, Yann, Mezzanotte, Laura, de Jong, Marion, Löwik, Clemens W. G. M., Panth, Kranthi M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7497446/
https://ncbi.nlm.nih.gov/pubmed/32514888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-020-01511-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi